These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9110103)

  • 1. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
    Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
    Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women.
    Terao T; Nakamura J; Yoshimura R; Ohmori O; Takahashi N; Kojima H; Soeda S; Shinkai T; Nakano H; Okuno T
    Psychiatry Res; 2000 Oct; 96(2):167-73. PubMed ID: 11063789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study.
    Pitchot W; Wauthy J; Legros JJ; Ansseau M
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and temperature responses to the 5-HT1A receptor agonist flesinoxan in normal volunteers.
    Pitchot W; Wauthy J; Hansenne M; Pinto E; Fuchs S; Reggers J; Legros JJ; Ansseau M
    Psychopharmacology (Berl); 2002 Oct; 164(1):27-32. PubMed ID: 12373416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.
    Nappi RE; Sances G; Brundu B; De Taddei S; Sommacal A; Ghiotto N; Polatti F; Nappi G
    Hum Reprod; 2005 Dec; 20(12):3423-8. PubMed ID: 16123089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Biol Psychiatry; 1997 Jun; 41(11):1071-86. PubMed ID: 9146818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen augments serotonergic activity in postmenopausal women.
    Halbreich U; Rojansky N; Palter S; Tworek H; Hissin P; Wang K
    Biol Psychiatry; 1995 Apr; 37(7):434-41. PubMed ID: 7786956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic responsivity in trichotillomania: neuroendrocrine effects of m-chlorophenylpiperazine.
    Stein DJ; Hollander E; Cohen L; Simeon D; Aronowitz B
    Biol Psychiatry; 1995 Mar; 37(6):414-6. PubMed ID: 7772651
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
    Lindenmayer JP; Adityanjee ; Vital-Herne M; Bark N; Grochowski S; Moynihan N
    Biol Psychiatry; 1997 Jul; 42(1):6-12. PubMed ID: 9193736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
    Kahn RS; Siever LJ; Gabriel S; Amin F; Stern RG; DuMont K; Apter S; Davidson M
    Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls.
    Garcia-Borreguero D; Jacobsen FM; Murphy DL; Joseph-Vanderpool JR; Chiara A; Rosenthal NE
    Biol Psychiatry; 1995 May; 37(10):740-9. PubMed ID: 7640329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS; Westenberg HG
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
    Feuchtl A; Bagli M; Stephan R; Frahnert C; Kölsch H; Kühn KU; Rao ML
    Pharmacopsychiatry; 2004 Jul; 37(4):180-8. PubMed ID: 15467976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
    Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
    Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.
    Mueller EA; Murphy DL; Sunderland T
    Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
    Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
    Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures.
    Stein DJ; Hollander E; DeCaria CM; Simeon D; Cohen L; Aronowitz B
    Biol Psychiatry; 1996 Sep; 40(6):508-13. PubMed ID: 8879471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.